5-Fluorouracil derivatives. XXII. Synthesis and antitumor activities of 1-carbamoyl-5-fluorouracils. 1997

S Ozaki, and X Kong, and Y Watanabe, and T Hoshiko, and T Koga, and T Ogasawara, and T Takizawa, and H Fujisawa, and M Iigo, and A Hoshi
Department of Chemistry, Shandong University, Jinan, China.

Fifty-four 1-carbamoyl-5-fluorouracils were synthesized from 5-fluorouracil and isocyanate or amine. Antitumor activity was tested in the L-1210 tumor system, and 11 compounds gave better values of therapeutic ratio than HCFU (1-hexylcarbamoyl-5-fluorouracil). 1-(4-Methoxycyclohexylcarbamoyl)-5-fluorouracil gave the best result.

UI MeSH Term Description Entries
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D008297 Male Males
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

S Ozaki, and X Kong, and Y Watanabe, and T Hoshiko, and T Koga, and T Ogasawara, and T Takizawa, and H Fujisawa, and M Iigo, and A Hoshi
July 1985, Chemical & pharmaceutical bulletin,
S Ozaki, and X Kong, and Y Watanabe, and T Hoshiko, and T Koga, and T Ogasawara, and T Takizawa, and H Fujisawa, and M Iigo, and A Hoshi
January 1986, Chemical & pharmaceutical bulletin,
S Ozaki, and X Kong, and Y Watanabe, and T Hoshiko, and T Koga, and T Ogasawara, and T Takizawa, and H Fujisawa, and M Iigo, and A Hoshi
February 1984, Chemical & pharmaceutical bulletin,
S Ozaki, and X Kong, and Y Watanabe, and T Hoshiko, and T Koga, and T Ogasawara, and T Takizawa, and H Fujisawa, and M Iigo, and A Hoshi
September 1987, Chemical & pharmaceutical bulletin,
S Ozaki, and X Kong, and Y Watanabe, and T Hoshiko, and T Koga, and T Ogasawara, and T Takizawa, and H Fujisawa, and M Iigo, and A Hoshi
December 1975, Gan,
S Ozaki, and X Kong, and Y Watanabe, and T Hoshiko, and T Koga, and T Ogasawara, and T Takizawa, and H Fujisawa, and M Iigo, and A Hoshi
January 1996, Medicinal research reviews,
S Ozaki, and X Kong, and Y Watanabe, and T Hoshiko, and T Koga, and T Ogasawara, and T Takizawa, and H Fujisawa, and M Iigo, and A Hoshi
August 1985, Chemical & pharmaceutical bulletin,
S Ozaki, and X Kong, and Y Watanabe, and T Hoshiko, and T Koga, and T Ogasawara, and T Takizawa, and H Fujisawa, and M Iigo, and A Hoshi
December 1982, Chemical & pharmaceutical bulletin,
S Ozaki, and X Kong, and Y Watanabe, and T Hoshiko, and T Koga, and T Ogasawara, and T Takizawa, and H Fujisawa, and M Iigo, and A Hoshi
May 1998, Yao xue xue bao = Acta pharmaceutica Sinica,
S Ozaki, and X Kong, and Y Watanabe, and T Hoshiko, and T Koga, and T Ogasawara, and T Takizawa, and H Fujisawa, and M Iigo, and A Hoshi
October 1980, Cancer research,
Copied contents to your clipboard!